Researchers report they have been able to create tiny, biodegradable nanoparticles which are able to carry DNA to brain cancer cells in mice. Read More
Researchers have developed a new approach that uses microRNA in combination with chemotherapy to help treat glioblastoma brain cancer. In preclinical models, the approach increases survival of the deadly brain cancer five fold. Read More
Recurrent gliomas could have genetic profiles which are different from those of the initial tumors that spawned them, a new study reports. Read More
Meningioma, the most common primary brain tumor in the United States, accounts for about 33 percent of all primary brain... Read More
Researchers shed light on how the Notch pathway can suppress the formation of some types of brain cancer tumors. Read More
New research reveals two common gene variants which lead to longer telomeres also significantly increase the risk of developing gliomas. Read More
Artificial IntelligenceBrain CancerDeep LearningFeaturedMachine LearningNeurologyNeuroscienceNeurotech
··3 min readA new machine learning algorithm can predict which tumors were lower-grade gliomas or glioblastoma brain cancer with a high degree of accuracy. Read More
Researchers at UT Southwestern Medical Center have developed what they believe to be the first clinical application of a new... Read More
Researchers discovered changes in thousands of genes induced by the tumor microenvironment. The study may help in identifying new biomarkers for the early detection, and subsequent treatment, of brain cancers. Read More
Researchers report preoperative nTMS analysis of motor areas improves patient prognosis for malignant brain tumors. Read More
Study is first to show feasibility and efficacy of a new use for autologous stem cell transplant. For the first... Read More
Researchers at the Stanford University School of Medicine and Lucile Packard Children’s Hospital have identified several gene mutations responsible for the most common childhood brain tumor, called medulloblastoma, adding evidence to the theory that the diagnosis is a group of genetically distinct cancers with different prognoses. These and accompanying findings are likely to lead to less toxic, better targeted treatment approaches over the next two years, the researchers said. Read More
